These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37489729)

  • 1. Clinical Outcomes and Predictors of Long-Term Survival in Patients With and Without Previously Known Extracardiac Sarcoidosis Using Machine Learning: A Swedish Multicenter Study.
    Bobbio E; Eldhagen P; Polte CL; Hjalmarsson C; Karason K; Rawshani A; Darlington P; Kullberg S; Sörensson P; Bergh N; Bollano E
    J Am Heart Assoc; 2023 Aug; 12(15):e029481. PubMed ID: 37489729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac sarcoidosis outcome differences: A comparison of patients with de novo cardiac versus known extracardiac sarcoidosis at presentation.
    Rosen NS; Pavlovic N; Duvall C; Wand AL; Griffin JM; Okada DR; Chrispin J; Tandri H; Mathai SC; Stern B; Pardo CA; Kasper EK; Sharp M; Chen ES; Gilotra NA
    Respir Med; 2022 Jul; 198():106864. PubMed ID: 35550245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis, management, and outcome of cardiac sarcoidosis and giant cell myocarditis: a Swedish single center experience.
    Bobbio E; Hjalmarsson C; Björkenstam M; Polte CL; Oldfors A; Lindström U; Dahlberg P; Bartfay SE; Szamlewski P; Taha A; Sakiniene E; Karason K; Bergh N; Bollano E
    BMC Cardiovasc Disord; 2022 Apr; 22(1):192. PubMed ID: 35473644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiologic testing for diagnostic evaluation and risk stratification in patients with suspected cardiac sarcoidosis with preserved left and right ventricular systolic function.
    Zipse MM; Tzou WS; Schuller JL; Aleong RG; Varosy PD; Tompkins C; Borne RT; Tumolo AZ; Sandhu A; Kim D; Freeman AM; Weinberger HD; Maier LA; Sung RK; Nguyen DT; Sauer WH
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1939-1948. PubMed ID: 31257683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of extracardiac sarcoidosis on clinical outcomes in patients with cardiac sarcoidosis: Importance of continued screening for cardiac involvement.
    Takaya Y; Nakagawa K; Miyoshi T; Nishii N; Morita H; Nakamura K; Yuasa S
    Int J Cardiol; 2024 Oct; 413():132368. PubMed ID: 39025136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manifestations and Outcome of Cardiac Sarcoidosis and Idiopathic Giant Cell Myocarditis by 25-Year Nationwide Cohorts.
    Nordenswan HK; Lehtonen J; Ekström K; Räisänen-Sokolowski A; Mäyränpää MI; Vihinen T; Miettinen H; Kaikkonen K; Haataja P; Kerola T; Rissanen TT; Kokkonen J; Alatalo A; Pietilä-Effati P; Utriainen S; Kupari M
    J Am Heart Assoc; 2021 Mar; 10(6):e019415. PubMed ID: 33660520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Correlates of Early Right Ventricular Dysfunction in Sarcoidosis and Its Association with Outcome.
    Joyce E; Kamperidis V; Ninaber MK; Katsanos S; Debonnaire P; Schalij MJ; Taube C; Bax JJ; Delgado V; Ajmone Marsan N
    J Am Soc Echocardiogr; 2016 Sep; 29(9):871-8. PubMed ID: 27450364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcome in Probable Versus Absolute Cardiac Sarcoidosis.
    Simonen P; Lehtonen J; Kupari M
    Am J Cardiol; 2019 Feb; 123(4):674-678. PubMed ID: 30527771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and predictive value of speckle tracking echocardiography in cardiac sarcoidosis.
    Di Stefano C; Bruno G; Arciniegas Calle MC; Acharya GA; Fussner LM; Ungprasert P; Cooper LT; Blauwet LA; Ryu JH; Pellikka PA; Carmona Porquera EM; Villarraga HR
    BMC Cardiovasc Disord; 2020 Jan; 20(1):21. PubMed ID: 31959111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Outcomes of Cardiac Sarcoid: Prognostic Implications of Isolated Cardiac Involvement and Impact of Diagnostic Delays.
    Sink J; Joyce C; Liebo MJ; Wilber DJ
    J Am Heart Assoc; 2023 Oct; 12(19):e028342. PubMed ID: 37750587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of outcome in a contemporary cardiac sarcoidosis population: Role of brain natriuretic peptide, left ventricular function and myocardial inflammation.
    Kouranos V; Khattar RS; Okafor J; Ahmed R; Azzu A; Baksi JA; Wechalekar K; Cowie MR; Wells AU; Lüscher TF; Sharma R
    Eur J Heart Fail; 2023 Dec; 25(12):2287-2298. PubMed ID: 37877328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Right Ventricular Abnormalities on Cardiovascular Magnetic Resonance Imaging in Patients With Sarcoidosis.
    Velangi PS; Chen KA; Kazmirczak F; Okasha O; von Wald L; Roukoz H; Farzaneh-Far A; Markowitz J; Nijjar PS; Bhargava M; Perlman D; Akçakaya M; Shenoy C
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1395-1405. PubMed ID: 31954639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance.
    Murtagh G; Laffin LJ; Beshai JF; Maffessanti F; Bonham CA; Patel AV; Yu Z; Addetia K; Mor-Avi V; Moss JD; Hogarth DK; Sweiss NJ; Lang RM; Patel AR
    Circ Cardiovasc Imaging; 2016 Jan; 9(1):e003738. PubMed ID: 26763280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis and risk stratification in cardiac sarcoidosis patients with preserved left ventricular ejection fraction.
    Chiba T; Nakano M; Hasebe Y; Kimura Y; Fukasawa K; Miki K; Morosawa S; Takanami K; Ota H; Fukuda K; Shimokawa H
    J Cardiol; 2020 Jan; 75(1):34-41. PubMed ID: 31277963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the frontal QRS-T angle with adverse cardiac remodeling, impaired left and right ventricular function, and worse outcomes in heart failure with preserved ejection fraction.
    Selvaraj S; Ilkhanoff L; Burke MA; Freed BH; Lang RM; Martinez EE; Shah SJ
    J Am Soc Echocardiogr; 2014 Jan; 27(1):74-82.e2. PubMed ID: 24075945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres.
    Fussner LA; Karlstedt E; Hodge DO; Fine NM; Kalra S; Carmona EM; Utz JP; Isaac DL; Cooper LT
    Eur J Heart Fail; 2018 Dec; 20(12):1713-1720. PubMed ID: 30378224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications.
    Viles-Gonzalez JF; Pastori L; Fischer A; Wisnivesky JP; Goldman MG; Mehta D
    Chest; 2013 Apr; 143(4):1085-1090. PubMed ID: 23667912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural History of Patients Diagnosed with Cardiac Sarcoidosis at Left Ventricular Assist Device Implantation or Cardiac Transplantation.
    Schmidt TJ; Rosenbaum AN; Kolluri N; Stulak JM; Daly RC; Schirger JA; Elwazir MY; Kapa S; Cooper LT; Blauwet LA
    ASAIO J; 2021 May; 67(5):583-587. PubMed ID: 33902104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Updated Japanese Circulation Society Guidelines to Diagnose Isolated Cardiac Sarcoidosis.
    Sato K; Kawamatsu N; Yamamoto M; Machino-Ohtsuka T; Ishizu T; Ieda M
    J Am Heart Assoc; 2022 Jul; 11(13):e025565. PubMed ID: 35766294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and prognosis of patients with isolated cardiac sarcoidosis: Insights from the ILLUMINATE-CS study.
    Maeda D; Matsue Y; Dotare T; Sunayama T; Iso T; Yoshioka K; Nabeta T; Naruse Y; Kitai T; Taniguchi T; Tanaka H; Okumura T; Baba Y; Minamino T
    Eur J Heart Fail; 2024 Jan; 26(1):77-86. PubMed ID: 37823255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.